Oxygenta Pharmaceutical Ltd. logo

Oxygenta Pharmaceutical Ltd. (OXYGENTAPH)

Market Closed
11 Aug, 22:00
MSE MSE
65. 64
+9.84
+17.6344%
1.79B Market Cap
- P/E Ratio
- Div Yield
33,300 Volume
0 Eps
55.8
Previous Close
Add Transaction
Day Range
54.75 65.64
Year Range
43 102.7
Want to track OXYGENTAPH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Oxygenta Pharmaceutical Ltd. (OXYGENTAPH) Statistics

Valuation metrics

Market Cap 1.79B
Enterprise value 3.06B
Trailing P/E (ttm) -14.64
Forward P/E -
PEG ratio -3.14
Price/Sales (ttm) 1.47
Price/Book (mrq) -4.64
Enterprise Value/Revenue 2.27
Enterprise Value/EBITDA -37.99

Overview

Shares outstanding 36.98M
Float 3.5M
Shares short -
% Held by insiders 0.88%
% Held by institutions -
Average volume (10 days) 9.57K
Average volume (90 days) 8.48K

Price summary

52-Week low 43
52-Week high 102.7
Beta 0.43
50-Day moving average 49.15
200-Day moving average 52.14

Financials

Fiscal year

Fiscal year ends 31 Mar 2025
Most recent quarter (mrq) 31 Dec 2025

Profitability

Profit margin -0.1%
Operating margin -0.08%

Operational effectiveness

Return on assets -0.11%
Return on equity 0.39%

Income Statement

Revenue (ttm) 1.13B
Revenue per share (ttm) 36.45
Quarterly revenue growth (yoy) 0.02%
Gross profit (ttm) -42.34M
EBITDA -186.36M
Net income to common (ttm) -174.51M
Diluted EPS (ttm) -3.67
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) 12.4M
Total cash per share (mrq) 0.58
Total debt (mrq) 728.29M
Total Debt/Equity (mrq) -2.57
Current ratio (mrq) 0.6%
Book value per share (mrq) -11.54

Cash Flow

Cash flow statement -61.06M
Levered free cash flow (LFCF) -96.83M